DaVita (NYSE:DVA) Downgraded by StockNews.com to “Hold”

DaVita (NYSE:DVA) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday.

Other equities analysts have also issued research reports about the stock. Barclays increased their target price on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. Cowen reaffirmed a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price objective on DaVita in a report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, DaVita currently has an average rating of “Hold” and a consensus price target of $166.33.

DaVita Stock Performance

NYSE:DVA opened at $153.79 on Wednesday. DaVita has a 1 year low of $125.64 and a 1 year high of $179.60. The business has a fifty day simple moving average of $156.16 and a two-hundred day simple moving average of $157.39. The company has a market capitalization of $12.30 billion, a P/E ratio of 14.32, a P/E/G ratio of 1.07 and a beta of 0.99. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, analysts expect that DaVita will post 10.76 earnings per share for the current year.

Institutional Investors Weigh In On DaVita

Several large investors have recently added to or reduced their stakes in DVA. United Capital Financial Advisors LLC lifted its holdings in shares of DaVita by 2.6% in the 4th quarter. United Capital Financial Advisors LLC now owns 2,416 shares of the company’s stock worth $361,000 after acquiring an additional 62 shares during the last quarter. Freedom Investment Management Inc. boosted its position in DaVita by 3.6% in the 4th quarter. Freedom Investment Management Inc. now owns 1,790 shares of the company’s stock valued at $268,000 after buying an additional 62 shares during the period. MML Investors Services LLC grew its stake in DaVita by 1.3% in the 3rd quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock worth $869,000 after acquiring an additional 68 shares in the last quarter. Exchange Traded Concepts LLC increased its position in shares of DaVita by 8.3% during the fourth quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock worth $133,000 after acquiring an additional 68 shares during the period. Finally, Wealth Enhancement Advisory Services LLC raised its stake in shares of DaVita by 2.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company’s stock valued at $531,000 after acquiring an additional 69 shares in the last quarter. 90.12% of the stock is owned by institutional investors.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.